NCT02473809View on ClinicalTrials.gov

The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

PHASE4CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

Diabetes ComplicationsOsteoporosis

Interventions

DRUG

Liraglutide

Once daily

DRUG

Placebo

Once daily

Trial Locations (1)

8000

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Aarhus University Hospital

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Aarhus

OTHER